Combining tertiary lymphoid structures and tumor stroma percentage for predicting prognosis and chemotherapy benefits in stage II-III colorectal cancer
{{output}}
Background: The current tumor-node-metastasis (TNM) staging system is insufficient for predicting the prognosis and chemotherapeutic benefits in stage II-III colorectal cancer (CRC) patients. We aimed to evaluate whether tertiary... ...
